Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a randomized clinical trial that will be carried out in people with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic exercise combine with sexual education, and the control group (CG) who will receive the therapeutic exercise program.
The participants will be evaluated at three moments: before starting the study (T1), after the 8-week treatment program (T2) and after 4 weeks of follow-up in which they will be encouraged to continue with the treatment (T3). Objective and subjective data of the participants will be evaluated. T1 will be assessed with a sociodemographic questionnaire and the FSFI and MSSCQ surveys. T2 and T3 will assess blood pressure, heart rate, variability of the autonomic system, the ability to dissociate the lumbopelvic movement from the thoracolumbar, measurement of the muscles of the transverse, internal and external obliques, the distance between the rectus abdominis and the pelvic floor, subjective perception of effort during exercise and subjective perception of orgasmic intensity.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Therapeutic Exercise | Active Comparator | They will recive the therapeutic exercise program. |
|
| Therapeutic exercise and sexual education | Experimental | They will receive ta combined program, which will combine therapeutic exercise with a sexual education classes. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Therapeutic Exercise | Procedure | It will consist of an 8-week intervention divided into 2 weekly sessions, in which functional exercise will be combined with aerobic exercise. A progressive protocol will be carried out.The sessions will last approximately 60 minutes divided into a first aerobic part which will serve as a warm-up for the functional part, then a main part with approximately 6 exercises and, finally, a cool-down of 3 to 5 minutes with relaxation exercises and stretching. |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life - Sexual Function | The Index of Female Sexual Function (IFSF) will be used. It is a multidimensional self-reported instrument for the evaluation of female sexual function. The scores for the same domain are added together and multiplied by the factor that corresponds to each domain. The total score is obtained by adding the scores for the 6 domains. A score of 0 in any of the domains indicates a lack of sexual activity in the last month.The maximum total score will be 36 points and the minimum 2. The higher the score, the better the sexual function. | Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program). |
| Quality of Life - Sexual self-concept | Multidimensional Scale of Sexual Concept (MSSCQ) will be used. It is a multidimensional self-reported instrument for the evaluation of sexual self- concept. Each answer has a score of 0 to 4 points. The higher the score, the better the sexual assertiveness and sexual self-concept. There are a total of 16 questions. The maximum score is 64 points and the minimum is 0. | Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program). |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life - Pleasure | Visual Analogue Scale (VAS) of pleasure will be used. Orgasmic intensity is reported through a Likert scale (0-10) and a chromatic gradation, which fluctuate from 0 (white), corresponding to the absence of orgasmic intensity, to 10 (deep red), corresponding to the highest level of orgasmic intensity. | Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program). |
| Measure | Description | Time Frame |
|---|---|---|
| Excitation | Sphygmomanometer will be used to measure the patients' arousal. Blood pressure will be measured to assess the level of arousal. Blood pressure is controlled by the autonomic system, which is also responsible for arousal. The higher the blood pressure, the greater the activation of the sympathetic system. Lower blood pressures indicate that the parasympathetic system is more active. | Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program). |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Laura Fuentes Aparicio | Valencia | 46010 | Spain | |||
| University of Valencia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Therapeutic exercise and sexual education | Combination Product | The sexual education part will consist of a 4-week intervention divided into 1 session every two weeks in an online format, in which topics related to the pathology and self-knowledge will be addressed. The sessions will last approximately 60 minutes, divided into a first part of reception and welcome of the group (lasting approximately 5-10 minutes), then the main content will be divided differently in each session (the explicit content of each session will be detailed later) and will end with a farewell and closing of the online session (lasting approximately 5-10 minutes) together with the explanation of the homework. In addition, they will also carry out the therapeutic exercise protocol. |
|
| Physical-Funcionality - Motor control | Determine motor control: clinical test of lumpopelvic and thoracolumbar dissociation will be used. The clinical test assesses the ability to dissociate lumbopelvic movement from that of the thoracolumbar junction, and to evaluate the inter-rater reliability of the test in individuals with and without low back pain (LBP) when performed by experienced and novice therapists. A clinical scale was developed to characterise quality of performance of lumbopelvic motion with limited motion at the thoracolumbar junction. The patient is asked to flex the trunk to see if there is lumbopelvic dissociation. | Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program). |
| Physical-Funcionality- Pelvic floor and abdominal ultrasound | The ultrasound will measure muscle tone. This tone will be assessed in different situations. Measurement of basal tone, tone at maximum contraction, tone at Valsalva and tone at cough. | Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program). |
| Excitation | Electrocardiogram will be used to measure the patients' arousal. The electrocardiogram measures heart rate. It is also measured by the autonomic nervous system, so it is closely related to excitement. During excitement, a person's heart rate increases. | Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program). |
| Excitation | eSense skin response will be used to measure the patients' arousal. The activation of the sympathetic and parasympathetic systems is recorded through the skin. Higher values and the red colour measured with the eSense device indicate that the sympathetic system is more active. If the values tend to 0 and the colour is green, there is more activation of the parasympathetic system. | Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program). |
| Valencia |
| 46010 |
| Spain |
| ID | Term |
|---|---|
| D004715 | Endometriosis |
| D012725 | Sexual Behavior |
| ID | Term |
|---|---|
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D005081 | Exercise Therapy |
| ID | Term |
|---|---|
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
Not provided
Not provided